Vinge Logotype
SvenskaEnglish 18D7E0DE-2035-40AE-A740-8F45A358A8F4 Login
  1. Home
  2. Mandates
  3. Vinge is advising the Sixth AP-fund in connection with the sale of Gnotec
Mandate

Vinge is advising the Sixth AP-fund in connection with the sale of Gnotec

March 26, 2013

Vinge is advising the Sixth AP-fund in connection with the sale of Gnotec AB to Frauenthal. Closing of the transaction is subject to applicable competition law approvals and other customary closing conditions.

The Vinge team advising the Sixth AP-fund includes partner Fredrik Sonander and associates Karin Wisenius and Gabriel Westin.

Related

Vinge has advised Oncopeptides in connection with a directed share issue

 Vinge has advised Oncopeptides in connection with a directed share issue, whereby Oncopeptides raises proceeds of SEK 100 million.
October 16, 2026

Vinge advises KGAL on its divestment of a Nordic wind portfolio to Enordic Evergreen

 Vinge has advised KGAL on the divestment of a Nordic onshore wind portfolio to Enordic Evergreen.
October 14, 2026

Vinge has advised Orexo in connection with its rights issue

 Vinge has advised Orexo AB (publ) in connection with a partially guaranteed rights issue of approximately SEK 250 million before transaction costs, subject to approval by an extraordinary general meeting.
October 09, 2026